Antibody (Suitable for clinical applications)
Specification | Recommendation |
---|---|
Recommended Dilution (Conc) | 1:50-1:100 |
Pretreatment | No Pretreatment Required |
Incubation Parameters | 30 min at Room Temperature |
Prior to use, inspect vial for the presence of any precipitate or other unusual physical properties. These can indicate that the antibody has degraded and is no longer suitable for patient samples. Please run positive and negative controls simultaneously with all patient samples to account and control for errors in laboratory procedure. Use of methods or materials not recommended by enQuire Bio including change to dilution range and detection system should be routinely validated by the user.
Prostate Specific Membrane Antigen Information for Pathologists
Summary:
750 Amino acid, 100 KDa, type II membrane glycoprotein with both folate hydrolase and N-acetylated-alpha-linked-acidic peptidase (NAALAD) activity. Assists with folate uptake and modulates excitatory neurotransmissions in brain. In contrast to PSA, upregulated with androgen deprivation (Rev Urol 2004;6:S13). Diagrams / tables Image hosted on other severs:.
Common Uses By Pathologists:
Serum PSMA: detected in serum by RT-PCR, but its role in prostatic carcinoma screening is controversial (Prostate 1998;36:181, Clin Cancer Res 1999;5:4034). Tissue PSMA:. Expressed in high grade prostatic adenocarcinoma, in contrast to PSA. PSMA / PSA ratio by IHC. Almost equal in normal prostate.
Prostate Specific Membrane Antigen General Information | |
---|---|
Alternate Names | |
Molecular Weight | |
84.3 kDa | |
Chromosomal Location | |
p11.12 [chr: 11] [chr_start: 49145092] [chr_end: 49208638] [strand: -1] | |
Curated Database and Bioinformatic Data | |
Gene Symbol | FOLH1 |
Entrez Gene ID | 2346 |
RefSeq Protein Accession(s) | XP_016872926; XP_016872934; NP_001014986; XP_016872936; NP_001180400; XP_016872923; NP_001180401; NP_001180402; NP_004467; XP_016872933; XP_016872924; XP_016872935; XP_016872937; XP_016872925; XP_016872931; XP_016872932 |
RefSeq mRNA Accession(s) | NM_001351236; NM_001193473; XM_017017434; XM_017017446; XM_024448411; XR_001747819; XM_017017444; XM_017017448; NM_001193472; XM_017017445; XM_017017451; NM_001014986; NM_004476; XM_011519958; XM_017017433; XM_017017435; XM_017017447; XM_017017449; XM_017017450; XM_017017432; XR_001747818; NM_001193471 |
RefSeq Genomic Accession(s) | NG_029170; NC_000011 |
UniProt ID(s) | Q04609 |
PharmGKB ID(s) | PA28205 |
KEGG Gene ID(s) | hsa:2346 |
General Description of Prostate Specific Membrane Antigen . | |
PSMA is a 750 amino acid type II membrane glycoprotein. PSMA is expressed in normal and malignant prostatic epithelium and in a subset of non-prostatic tissues. PSMA expression has been shown to correlate with the progression of prostate cancer, with highest levels expressed in hormone-refractory and metastatic disease. PSMA expresses in the neovasculature of a variety of non-prostatic solid tumors. |
There are no reviews yet.